Heparanase expression correlates with malignant potential in human colon cancer (original) (raw)
References
Albini A (1998) Tumor and endothelial cell invasion of basement membranes. The matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms. Pathol Oncol Res 4: 230–241 CASPubMed Google Scholar
Beahrs OH (1982) Colorectal cancer staging as a prognostic feature. Cancer 50: 2615–2617 CASPubMed Google Scholar
Black DA, Waugh JM (1948) The intramural extension of carcinoma at the descending colon, sigmoid, and rectosigmoid. A Pathologic study. Surg Gynecol Obstet 84: 457–461 Google Scholar
Chapuis PH, Dent OF, Fisher R, Newland RC, Pheils MT, Smyth E, Colquhoun K (1985) A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 72: 698–702 Google Scholar
Dukes CE, Bussey HJR (1958) The spread of rectal cancer and its effect on progress. Br J Cancer 12: 309–320 CASPubMed Google Scholar
Freeman C, Parish CR (1997) A rapid quantitative assay for the detection of mammalian heparanase activity. Biochem J 325:229–237 CASPubMed Google Scholar
Friedmann Y, Vlodavsky I, Aingorn H, Aviv A, Peretz T, Pecker I, Pappo O (2000) Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis. Am J Pathol 157:1167–1175 CASPubMed Google Scholar
Gohji K, Okamoto M, Kitazawa S, Toyoshima M, Dong J, Katsuoka Y, Nakajima M (2001) Heparanase protein and gene expression in bladder cancer. J Urol 166: 1286–1290 CASPubMed Google Scholar
Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EWJr (1994) Identification of occult micrometastases in pericolic lymph nodes of Duke’s B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 73: 563–569 CASPubMed Google Scholar
Inoue H, Mimori K, Utsunomiya T, Sadanaga N, Barnard GF, Ueo H, Mori M (2001) Heparanase expression in clinical digestive malignancies. Oncol Rep 8:539–542 CASPubMed Google Scholar
Jackson RL, Busch SJ, Cardin AL (1991) Glycosaminoglycans: molecular properties, protein interactions and role in physiological processes. Physiol Rev 71:481–539 CASPubMed Google Scholar
Kjellen L, Lindahl U (1991) Proteoglycans: structures and interactions. Annu Rev Biochem 60:443–475 CASPubMed Google Scholar
Koliopanos A, Friess H, Kleeff J, Shi X, Liao Q, Packer I, Vlodavsky I, Zimmermann A, Buchler MW (2001) Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res 61:4655–4659 CASPubMed Google Scholar
Kramer RH, Vogel KG, Nicolson GL (1982) Solubilization and degradation of sub-endothelial-matrix glycoproteins and proteoglycans by metastatic tumor cells. J Biol Chem 257:2678–2686 CASPubMed Google Scholar
Marchetti D, Reiland J, Erwin B, Roy M (2003) Inhibition of heparanase activity and heparanase-induced angiogenesis by suramin analogues. Int J Cancer 104:167–174 CASPubMed Google Scholar
Mikami S, Ohashi K, Ushii Y, Nemoto T, Katsube K, Yanagishita M, Nakajima M, Nakamura K, Koike M (2001) Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas. Jpn J Cancer Res 92: 1062–1073 CASPubMed Google Scholar
Nakajima M, Irimura N, Ferrante DD, Ferrante ND, Nicolson GL (1983) Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science 220:611–613 CASPubMed Google Scholar
Nakajima M, Irimura T, Nicolson GL (1988) Heparanase and tumor metastasis. J Cell Biochem 36:157–167 CASPubMed Google Scholar
Nakajima M, Morikawa K, Fabra A, Bucana CD, Fidler IJ (1990) Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst 82:1890–1898 CASPubMed Google Scholar
Nakajima M, DeChavigny A, Johnson CE, Hamada JI, Stein CA, Nicolson GL (1991) Suramin. A potent inhibitor of melanoma heparanase and invasion. J Biol Chem 266:9661–9666 CASPubMed Google Scholar
Naomoto Y, Kondo H, Tanaka N, Orita K (1987) Novel experimental models of human cancer metastasis in nude mice: lung metastasis, intraabdominal carcinomatosis with ascites, and liver metastasis. J Cancer Res Clin Oncol 113:544–549 CASPubMed Google Scholar
Newland RC, Chapuis PH, Pheils MT, MacPherson JG (1981) The relationship of survival to staging and grading of colorectal carcinoma: a prospective study of 503 cases. Cancer 47: 1424–1429 CASPubMed Google Scholar
Nishimura Y, Shitara E, Adachi H, Toyoshima M, Nakajima M, Okami Y, Takeuchi T (2000) Flexible synthesis and biological activity of uronic acid-type gem-diamine 1-N-iminosugars: a new family of glycosidase inhibitors. J Org Chem 65:2–11 CASPubMed Google Scholar
Nissen NN, Shankar R, Gamelli RL, Singh A, DiPietro LAI (1999) Heparin and heparan sulphate protect basic fibroblast growth factor from non-enzymic glycosylation. Biochem J 338:637–642 CASPubMed Google Scholar
Ohkawa T, Naomoto Y, Takaoka M, Nobuhisa T, Noma K, Motoki T, Murata T, Uetsuka H, Kobayashi M, Shirakawa Y, Yamatsuji T, Matsubara N, Matsuoka J, Haisa M, Gunduz M, Tsujigiwa H, Nagatsuka H, Hosokawa M, Nakajima M, Tanaka N (2004) Localization of heparanase in esophageal cancer cells: respective roles in prognosis and differentiation. Lab Invest (in press) Google Scholar
Parish CR, Freeman C, Brown KJ, Francis DJ, Cowden WB (1999) Identification of sulfate oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. Cancer Res 59:3433–3441 CASPubMed Google Scholar
Rohloff J, Zinke J, Schoppmeyer K, Tannapfel A, Witzigmann H, Mossner J, Wittekind C, Caca K (2002) Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma. Br J Cancer 86: 1270–1275 CASPubMed Google Scholar
Takaoka M, Naomoto Y, Ohkawa T, Uetsuka H, Shirakawa Y, Uno F, Fujiwara T, Gunduz M, Nagatsuka H, Nakajima M, Tanaka N, Haisa M (2003) Heparanase expression correlates with invasion and poor prognosis in gastric cancers. Lab Invest 83: 613–622 CASPubMed Google Scholar
Toyoshima M, Nakajima M (1999) Human heparanase. Purification, characterization, cloning, and expression. J Biol Chem 274: 24153–24160 CASPubMed Google Scholar
Vlodavsky I, Eldor A, Haimovitz-Friedman A, Matzner Y, Ishai-Michaeli R, Lider O, Naparstek Y, Cohen IR, Fuks Z (1992) Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis 12:112–127 CASPubMed Google Scholar
Vlodavsky I, Miao HQ, Benezra M, Lider O, Bar-Shavit R, Schmidt A (1997) Involvement of the extracellular matrix, heparan sulfate proteoglycans and heparan sulfate degrading enzymes in angiogenesis and metastasis. In: Lewis CE, Bicknell R, Ferrara N (eds) Tumor angiogenesis. Oxford University, Oxford, pp 125–140
Wight TN, Kinsella MG, Qwarntromn EE (1992) The role of proteoglycans in cell adhesion, migration and proliferation. Curr Opin Cell Biol 4:793–801 CASPubMed Google Scholar